Questions to Ask in an AI RCM Demo: A Buyer's Evaluation Scr...

You've scheduled the demo. The vendor has 45 minutes to convince you that their platform will transform your revenue cycle. They'll show you dashboards, walk through workflows, display impressive numbers, and tell you exactly what you want to hear.

Your job is to cut through the presentation and determine whether this platform will actually work — for your payers, your specialties, your EHR, your claims volume, and your team. The vendor is selling outcomes; you need to evaluate capabilities. The difference between those two things is the gap where bad purchasing decisions live.

This article provides the questions to ask before, during, and after an AI RCM demo — organized by evaluation category, with explanations of what good answers sound like and red flags that should make you pause.

Before the Demo: Preparation That Changes the Outcome

Most demo failures aren't the vendor's fault. They're the buyer's fault — for showing up unprepared, watching a canned presentation, and leaving without the information needed to make a decision.

Prepare Your Current Metrics

Bring these numbers to the demo. They turn a generic presentation into a specific conversation about your organization:

Denial rate (overall and by top 5 denial reasons)
First-pass acceptance rate
Days in accounts receivable (overall and by payer category)
Net collection rate
Cost per claim (or total RCM operational cost)
Annual billed charges and net revenue
EHR system (name and version)
Clearinghouse (current provider)
Top 10 payers (by claims volume)
Specialty mix (if multi-specialty)
Claims volume (monthly or annual)
Current coding process (in-house coders, outsourced, physician self-coding)

Define Your Must-Have vs. Nice-to-Have

Before seeing any demo, rank which revenue cycle functions are most critical for your organization:

Must-have (deal-breakers if absent):

AI-powered coding
Claims scrubbing and editing
Denial prediction and prevention
Eligibility verification
Prior authorization automation
Payment posting / ERA processing
Analytics and reporting
EHR integration (specific to your EHR)

Nice-to-have (valuable but not required):

Assemble the Right Team

The demo attendee list matters. Include:

Revenue cycle director/billing manager: Evaluates operational workflow and daily usability
IT representative: Evaluates integration architecture, security, and technical requirements
A hands-on biller or coder: Evaluates whether the actual interface works for the people who'll use it daily
Executive sponsor (CFO or VP of Finance): Evaluates financial model and strategic fit
Compliance officer (if possible): Evaluates audit trail and regulatory capabilities

Each attendee should come with their own evaluation questions specific to their domain.

During the Demo: Questions by Category

Category 1: AI Architecture and Capabilities

These questions determine whether the vendor's "AI" is genuine or marketing.

Q1: "Is AI the foundation of your platform, or was it added to an existing rules-based system?"

Why this matters: There's a fundamental difference between a platform built from the ground up with AI at its core (AI-native) and a legacy system that has added AI features on top of rules-based architecture. AI-native platforms learn from data across the entire revenue cycle; bolt-on AI only improves the specific module it's attached to.

Good answer: The vendor explains their AI architecture — when it was built, what data it trains on, how it improves over time. They can describe how AI in one module (e.g., coding) informs decisions in another module (e.g., denial prevention).

Red flag: "We've been adding AI capabilities over the past year" or "Our new AI module integrates with our existing platform." This suggests bolt-on AI, not native architecture.

Q2: "What specific AI/ML models power your platform? What are they trained on?"

Why this matters: "AI" can mean anything from a simple rules engine to a sophisticated neural network. Understanding what the models actually are — and what data they're trained on — separates genuine AI from glorified if/then logic.

Good answer: The vendor can explain (in appropriate detail for your audience) the types of models used — natural language processing for documentation analysis, classification models for denial prediction, pattern recognition for payer behavior. They explain the training data: millions of claims across thousands of providers, with ongoing learning from each client's data.

Red flag: "That's proprietary" without any substantive explanation. Evasiveness about training data. Inability to explain how the AI differs from rules-based automation.

Q3: "How does the AI learn from our specific data after deployment?"

Why this matters: A platform trained only on generic industry data will miss your payer-specific rules, your specialty's coding patterns, and your organization's unique denial trends. The AI should get smarter with your data over time.

Good answer: The vendor explains a specific learning loop — your claims, denials, and outcomes feed back into the model, improving predictions for your payers and specialties. They can give a timeline for when organization-specific learning becomes meaningful (typically 4-8 weeks).

Red flag: "The AI is pre-trained and doesn't need to learn from your data." This means it's a static model that won't adapt to your specific environment.

Q4: "Show me a claim that your AI would handle differently than a rules-based system."

Why this matters: This forces the vendor to demonstrate actual AI capability versus rules-based automation. Rules follow predetermined logic; AI identifies patterns that no one programmed.

Good answer: The vendor shows a specific example — perhaps a claim where the coding was technically correct but the AI predicted a denial based on subtle payer behavior patterns (a specific payer denying a specific code-diagnosis combination at a higher rate than industry average, even though the claim meets all stated requirements). Or an AI suggestion to add supporting documentation proactively because similar claims without that documentation were denied 40% of the time.

Red flag: The example could be accomplished with a simple rules engine (e.g., "the system checks for missing modifiers"). That's automation, not AI.

Category 2: Denial Prevention (Not Just Denial Management)

Q5: "Show me how a denial is predicted before the claim is submitted."

Why this matters: Anyone can manage denials after they happen. The value of AI is preventing denials before claims go out. This is the highest-value capability in the platform — if it works.

Good answer: The vendor walks through a live or realistic example: a claim is being prepared, the AI scores it with a denial probability (e.g., "78% chance of denial by UnitedHealthcare"), explains why (e.g., "this payer has denied modifier -25 on same-day E/M + injection claims at a 73% rate over the past 6 months"), and recommends a specific action (e.g., "add supporting documentation for the separate E/M service" or "split into two claims with different dates of service").

Red flag: The vendor can't demonstrate prediction — they can only show denial analytics after the fact. Or the "prediction" is simply rules-based edits (missing fields, invalid codes) that any claims scrubbing tool can catch.

Q6: "What's your false positive rate on denial predictions?"

Why this matters: A system that flags 50% of claims as "high denial risk" creates more work than it saves. The prediction needs to be precise enough that when the system flags a claim, the team trusts the flag and takes action.

Good answer: The vendor provides a specific number — typically 10-15% false positive rate for mature models. They explain how the rate decreases as the model learns from your specific data.

Red flag: "We don't track that" or "all our flags are accurate." No prediction model has a 0% false positive rate.

Q7: "What percentage of denials does your platform catch before submission, and what percentage still need to be worked after the fact?"

Why this matters: No platform prevents 100% of denials. Understanding the split between prevention (pre-submission) and management (post-denial) sets realistic expectations.

Good answer: "After 90 days of learning, our platform typically prevents 50-70% of historically denied claims from being denied. The remaining 30-50% are managed through automated appeal workflows." They provide client reference data to support the claim.

Red flag: "We eliminate denials." No platform eliminates denials. Some denials are caused by payer errors, policy changes, and situations that no AI can predict.

Category 3: Payer Intelligence

Q8: "How many payers are in your rules database? How often are payer rules updated?"

Why this matters: Healthcare has 900+ payers with constantly changing rules. The AI's payer coverage determines whether it can actually prevent denials for your specific payer mix.

Good answer: "We maintain active rule sets for [1,000+] payers, covering [95%+] of commercial claims volume nationally. Payer rules are updated [continuously / weekly / as changes are detected], not just at annual contract renewal."

Red flag: "We cover all major payers" without a specific number. Or updates happen quarterly — which means 3 months of denials from payer rule changes that the system didn't detect.

Q9: "Can I see rules and denial patterns for [your top 3 payers by name]?"

Why this matters: Generic payer coverage doesn't help if the platform doesn't have specific intelligence about your actual payers. Ask about your payers — by name.

Good answer: The vendor pulls up payer-specific data — denial trends, common denial reasons, rule sets, and behavioral patterns for the specific payers you name.

Red flag: "We'll need to check on that" or the data looks generic (same patterns for every payer).

Category 4: Integration and Technical Architecture

Q10: "How does your platform integrate with [your specific EHR]? Is it real-time or batch?"

Why this matters: Integration quality determines whether the platform can deliver real-time value (coding during documentation, eligibility at check-in, denial prediction before submission) or is limited to batch processing (overnight data dumps).

Good answer: For major EHRs (Epic, Oracle Health, athenahealth, eClinicalWorks), the vendor should have a pre-built integration with FHIR API or HL7 connections. They explain the specific data flow — what's real-time, what's near-real-time, and what's batch. They can demonstrate the integration or show it working at a reference client on the same EHR.

Red flag: "We can integrate with any EHR" without specifics on the method or timeline. Custom integrations add weeks to implementation and ongoing maintenance burden.

Q11: "What happens to our data if we terminate the contract?"

Why this matters: Data portability is a vendor lock-in indicator. You need to know that your claims data, analytics, and historical records are yours — not hostage to the vendor.

Good answer: "All your data is exportable in standard formats (CSV, HL7, FHIR). We provide a 90-day data export period after termination. Your data is deleted from our systems within [X] days of export confirmation."

Red flag: "Data export is available for a fee" or unclear timelines for data return. If getting your data out is difficult, the vendor is using it as a retention mechanism.

Q12: "What's the system's uptime SLA, and what happens during downtime?"

Why this matters: Revenue cycle operations are daily. A system that goes down during business hours stops claims from going out.

Good answer: "99.9%+ uptime SLA with documented redundancy and failover. We've had [X] hours of unplanned downtime in the past 12 months. During downtime, claims queue for processing and are automatically submitted when the system recovers."

Red flag: No SLA, or the vendor can't provide historical uptime data.

Category 5: Security and Compliance

Q13: "What certifications do you hold — SOC 2, HIPAA?"

Why this matters: In healthcare AI, certifications aren't nice-to-have — they're minimum requirements. Each certification covers different aspects of security and compliance.

Good answer: "We hold SOC 2 Type II [most recent audit date] and maintain full HIPAA compliance with a signed BAA. We can provide our SOC 2 report for your review."

Red flag: "We're HIPAA compliant" without SOC 2. HIPAA compliance is self-attested — there's no HIPAA certification body. Without independent third-party validation (SOC 2), the claim is unverifiable.

Q14: "Where is PHI stored? Is data encrypted at rest and in transit? Who has access?"

Why this matters: AI platforms process enormous volumes of protected health information. Understanding data handling architecture is essential for your compliance team.

Good answer: The vendor specifies the cloud infrastructure (AWS, Azure, GCP), data encryption standards (AES-256 at rest, TLS 1.2+ in transit), access control model (role-based, least privilege), and data isolation architecture (single-tenant vs. multi-tenant with logical isolation). They offer customer-managed encryption keys for organizations that require them.

Red flag: Vague answers about data location or encryption. "We follow industry best practices" without specifics. Inability to describe the access control model.

Q15: "Show me the audit trail for a coding decision."

Why this matters: In healthcare, every coding and billing decision must be auditable. AI decisions need the same traceability as human decisions — or better.

Good answer: The vendor demonstrates a complete audit trail: which documentation the AI evaluated, which codes were considered, why the selected codes were chosen, what rules were applied, and when any human review or modification occurred. Every step is timestamped and immutable.

Red flag: The AI produces codes without explainable reasoning. "Black box" AI that can't justify its decisions is a compliance liability — auditors need to understand why a code was selected.

Category 6: Implementation and Support

Q16: "What does your implementation timeline look like for an organization like ours?"

Why this matters: Implementation speed determines time to ROI. But unrealistically short timelines signal either a very limited platform or an optimistic vendor.

Good answer: A specific timeline based on your organization size, EHR, and complexity — typically 4-12 weeks for full optimization. The vendor breaks it into phases (discovery, integration, parallel run, go-live, optimization) with specific milestones and success criteria at each phase.

Red flag: "We can have you live in 2 days" (probably a very limited platform) or "implementation takes 6-12 months" (either very complex or very inefficient).

Q17: "What happens when something goes wrong after go-live? What's your support model?"

Why this matters: Post-go-live support is where many vendor relationships fail. The sales team moves on; the support team may not be as responsive.

Good answer: Named account manager or customer success contact. Defined support tiers with response time SLAs (e.g., critical issues: 1-hour response; standard issues: 4-hour response; questions: 24-hour response). Access to a support portal or direct line. Regular business reviews (monthly or quarterly) to review performance metrics.

Red flag: "Email our support team" without SLAs. No named contact. Support team is offshore with limited healthcare domain expertise.

Category 7: ROI and Measurement

Q18: "What metrics improve first, and when should we expect to see ROI?"

Why this matters: Sets realistic expectations and gives you milestones to track.

Good answer: "Eligibility verification improvements are visible immediately. Claims scrubbing accuracy improves within the first 2 weeks. Coding accuracy stabilizes by week 4-6. Denial rate reduction becomes measurable by week 6-8 as the AI learns your payer patterns. Most clients reach payback within 60-90 days."

Red flag: Promises of immediate dramatic improvement without acknowledging the AI learning curve.

Q19: "Can I see a live dashboard — not a demo environment, but real client data (anonymized)?"

Why this matters: Demo environments are designed to look impressive. Live dashboards reveal how the product actually performs in production.

Good answer: The vendor can show an anonymized production dashboard with real metrics — or arrange a call with a reference client who can share their experience, including their dashboard.

Red flag: "Our demo environment accurately represents the product" without offering production evidence. Or the demo looks dramatically different (better) than what reference clients describe.

Q20: "What happens if the platform doesn't deliver the projected ROI?"

Why this matters: The vendor's willingness to stand behind their projections indicates their confidence level.

Good answer: Performance guarantees tied to specific metrics (e.g., "if denial rate doesn't decrease by X% within 6 months, [specific remedy]"). Flexible contract terms that allow exit if performance thresholds aren't met. Transparent ROI tracking through the platform's analytics.

Red flag: Long-term contract commitments with no performance clauses. "Results vary" without any accountability mechanism.

Category 8: The Vendor

Q21: "What's your customer retention rate?"

Why this matters: Retention rate is the ultimate indicator of whether the product delivers value. A platform that works keeps its customers.

Good answer: "Our annual retention rate is [90%+]." They can share the number without hesitation. They're willing to discuss why clients who left did so (typically acquisition, closure, or internal changes — not product dissatisfaction).

Red flag: The vendor doesn't know their retention rate or won't share it.

Q22: "Can I speak with 2-3 reference clients — ideally in my specialty, on my EHR, at a similar size?"

Why this matters: References are the most reliable source of implementation reality. Vendor-selected references are inherently biased, but they still provide useful signal — especially when you ask specific questions.

Good answer: The vendor provides references without hesitation and can match your criteria (specialty, EHR, size) closely.

Questions to ask references:

What was implementation actually like? (How did it compare to what the vendor promised?)
How long until you saw measurable ROI?
What's the biggest improvement you've seen?
What's the biggest disappointment or limitation?
How responsive is support?
Would you buy again?

Red flag: The vendor stalls on references, provides only one, or references are from a completely different specialty/size/EHR.

Q23: "What's on your product roadmap for the next 12 months?"

Why this matters: You're buying a platform for years, not months. The roadmap signals whether the vendor is investing in the capabilities that matter to your future needs.

Good answer: The vendor shares a credible roadmap with specific features and approximate timelines. They explain their prioritization process (customer feedback, market demand, technology advancement).

Red flag: "We can build whatever you need" (no roadmap at all) or a roadmap full of features the vendor should have already built.

Red Flags to Watch For During Any Demo

These signals should trigger additional scrutiny regardless of which questions are asked:

The demo is entirely canned. The vendor walks through a predetermined script and won't deviate. They can't show your specific scenario or payer.

Every question gets a perfect answer. No product is perfect. A vendor who acknowledges limitations is more trustworthy than one who claims perfection.

"That's in our next release." One or two upcoming features are fine. If half your must-haves are "coming soon," you're buying a roadmap, not a product.

The demo shows outcomes but not workflow. Impressive dashboards showing 95% first-pass acceptance rates are meaningless if the vendor can't show you how a claim actually moves through the system.

The presenter can't answer technical questions. If the sales engineer defers every technical question to "someone who can follow up," the organization either can't support the product or didn't prepare for the demo.

They badmouth every competitor. Confident vendors differentiate on their own strengths. Insecure vendors attack competitors.

No live product demonstration. If the entire demo is slides and screenshots, you haven't seen the product. Insist on a live demonstration, even if it's a sandbox environment.

Post-Demo Evaluation Scorecard

After the demo, have each attendee score the platform independently before discussing as a group:

Category	Weight	Score (1-5)	Weighted Score
AI capabilities (genuine vs. marketing)	20%	___	___
Denial prevention demonstration	15%	___	___
Payer coverage and intelligence	15%	___	___
EHR integration (your specific EHR)	15%	___	___
Security and compliance	10%	___	___
Implementation timeline and approach	10%	___	___
Support model and references	10%	___	___
Pricing and ROI model	5%	___	___
Total weighted score	100%		___

Scoring guide:

5: Exceeded expectations — clear capability with evidence
4: Met expectations — demonstrated capability
3: Adequate — claimed capability but limited evidence
2: Below expectations — capability unclear or weak
1: Not demonstrated — couldn't answer or show capability

Decision thresholds:

4.0+: Strong candidate — proceed to contract negotiation
3.5-3.9: Qualified candidate — request follow-up demo on weak areas
3.0-3.4: Marginal — significant concerns to address before proceeding
Below 3.0: Not recommended — fundamental capability gaps